(1)
MarĂ­a Pellecchia, L.; Manuel Correa, F. J. Comparison of Clinical Efficacy and Dosing Regimens Between Nirsevimab and Palivizumab for Prophylaxis Against RSV in the Pediatric Population. SAP Primary Care 2025, 1, 18. https://doi.org/10.62486/pc202518.